Deficiency of vasodilator-stimulated phosphoprotein (VASP) increases blood-brain-barrier damage and edema formation after ischemic stroke in mice

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Kraft, Peter ^a   Benz, Peter Michael ^a   Austinat, Madeleine ^a   Brede, Marc Elmar ^a   Schuh, Kai ^a   Walter, Ulrich ^a   Stoll, Guido ^a   Kleinschnitz, Christoph ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRIPHENYLTETRAZOLIUM; VASODILATOR STIMULATED PHOSPHOPROTEIN; ACTIN; ACTIN BINDING PROTEIN; CELL ADHESION MOLECULE; PHOSPHOPROTEIN; VASODILATOR-STIMULATED PHOSPHOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD PRESSURE MEASUREMENT; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN SLICE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; HEART INFARCTION SIZE; HEMODYNAMICS; MALE; MEMBRANE DAMAGE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROANATOMY; NEUROMODULATION; NONHUMAN; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; ANOXIA; BRAIN; BRAIN INFARCTION; EDEMA; ISCHEMIA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; STROKE; TRANSGENIC MOUSE;

MUS;

ACTINS; ANIMALS; ANOXIA; BLOOD-BRAIN BARRIER; BRAIN; BRAIN INFARCTION; CELL ADHESION MOLECULES; EDEMA; FEMALE; HEMODYNAMICS; ISCHEMIA; MALE; MICE; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; PHOSPHOPROTEINS; STROKE;

EID: 78649930777     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015106     Document Type: Article

References (52)

1. Ayata C, Ropper AH (2002) Ischaemic brain oedema. J Clin Neurosci 9: 113-124.
2. Bardutzky J, Schwab S (2007) Antiedema therapy in ischemic stroke. Stroke 38: 3084-3094.
3. Qizilbash N, Lewington SL, Lopez-Arrieta JM (2002) Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev 2: CD000064.
4. Righetti E, Celani MG, Cantisani T, Sterzi R, Boysen G, et al. (2004) Glycerol for acute stroke. Cochrane Database Syst Rev 2: CD000096.
5. Bereczki D, Fekete I, Prado GF, Liu M (2007) Mannitol for acute stroke. Cochrane Database Syst Rev 183: CD001153.
6. Cecchelli R, Berezowski V, Lundquist S, Culot M, Renftel M, et al. (2007) Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov 6: 650-661.
7. Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, et al. (1999) Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci USA 96: 9815-9820.
8. Hordijk PL, Anthony E, Mul FP, Rientsma R, Oomen LC, et al. (1999) Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci 112: 1915-1923.
9. Dejana E (2004) Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5: 261-270.
10. Matter K, Balda MS (2003) Signalling to and from tight junctions. Nat Rev Mol Cell Biol 4: 225-236.
11. Lai CH, Kuo KH, Leo JM (2005) Critical role of actin in modulating BBB permeability. Brain Res Brain Res Rev 50: 7-13.
12. Mehta D, Malik AB (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 86: 279-367.
13. Mitic LL, Anderson JM (1998) Molecular architecture of tight junctions. Annu Rev Physiol 60: 121-142.
14. Sechi AS, Wehland J (2004) ENA/VASP proteins: multifunctional regulators of actin cytoskeleton dynamics. Front Biosci 9: 1294-1310.
15. Schlegel N, Burger S, Golenhofen N, Walter U, Drenckhahn Dl, et al. (2008) The role of VASP in regulation of cAMP- and Rac 1-mediated endothelial barrier stabilization. Am J Physiol Cell Physiol 294: C178-188.
16. Schlegel N, Waschke J (2009) VASP is involved in cAMP-mediated Rac 1 activation in microvascular endothelial cells. Am J Physiol Cell Physiol 296: C453-462.
17. Kris AS, Kamm RD, Sieminski AL (2008) VASP involvement in force-mediated adherens junction strengthening. Biochem Biophys Res Commun 375: 134-138.
18. Benz PM, Blume C, Moebius J, Oschatz C, Schuh K, et al. (2008) Cytoskeleton assembly at endothelial cell-cell contacts is regulated by alphaII-spectrin-VASP complexes. J Cell Biol 180: 205-219.
19. Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP (2002) Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability. FASEB J 16: 583-585.
20. Furman C, Sieminski AL, Kwiatkowski AV, Rubinson DA, Vasile E, et al. (2007) Ena/VASP is required for endothelial barrier function in vivo. J Cell Biol 179: 761-775.
21. Sporbert AK, Mertsch A, Smolenski RF, Haseloff G, Schonfelder M, et al. (1999) Phosphorylation of vasodilator-stimulated phosphoprotein: a consequence of nitric oxide- and cGMP-mediated signal transduction in brain capillary endothelial cells and astrocytes. Brain Res Mol Brain Res 67: 258-266.
22. Barone FC, Knudsen DJ, Nelson AH, Feuerstein GZ, Willette RN (1993) Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy. J Cereb Blood Flow Metab 13: 683-692.
23. Murakami K, Kondo T, Epstein CJ, Chan PH (1997) Overexpression of CuZnsuperoxide dismutase reduces hippocampal injury after global ischemia in transgenic mice. Stroke 28: 1797-1804.
24. Durukan A, Tatlisumak T (2007) Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87: 179-197.
25. Green RA, Odergren T, Ashwood T (2003) Animal models of stroke: do they have value for discovering neuroprotective agents? Trends Pharmacol Sci 24: 402-408.
26. Yamaguchi T, Suzuki M, Yamamoto M (1995) YM796, a novel muscarinic agonist, improves the impairment of learning behavior in a rat model of chronic focal cerebral ischemia. Brain Res 669: 107-114.
27. Kawamata T, Alexis NE, Dietrich WD, Finklestein SP (1996) Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab 16: 542-547.
28. Rosenberger P, Khoury J, Kong T, Weissmüller T, Robinson AM, et al. (2007) Identification of vasodilator-stimulated phosphoprotein (VASP) as an HIFregulated tissue permeability factor during hypoxia. FASEB J 21: 2613-2621.
29. Wu MH (2005) Endothelial focal adhesions and barrier function. J Physiol 569: 359-366.
30. Scott JA, Shewan AM, den Elzen NR, Loureiro JJ, Gertler FB, et al. (2006) Ena/ VASP proteins can regulate distinct modes of actin organization at cadherinadhesive contacts. Mol Biol Cell 17: 1085-1095.
31. Wojciak-Stothard B, Tsang LY, Haworth SG (2005) Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 288: L749-760.
32. Wojciak-Stothard B, Tsang LY, Paleolog E, Hall SM, Haworth SG (2006) Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 290: L1173-1182.
33. Kayyali US, Pennella CM, Trujillo C, Villa O, Gaestel M, et al. (2002) Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J Biol Chem 277: 42596-42602.
34. Filiano AJ, Bailey CD, Tucholski J, Gundemir S, Johnson GV (2008) Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling. FASEB J 22: 2662-2675.
35. Chen W, Jadhav V, Tang J, Zhang JH (2008) HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model. Neurobiol Dis 31: 433-441.
36. Chen C, Hu Q, Yan J, Yang X, Shi X, et al. (2009) Early inhibition of HIF- 1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol Dis 33: 509-517.
37. Davis BJ, Tang L, Zhang D, Mu X, Jiang V, et al. (2010) Role of vasodilator stimulated phosphoprotein in VEGF induced blood-brain barrier permeability in endothelial cell monolayers. Int J Dev Neurosci 28: 423-428.
38. Hicks K, O'Neil RG, Dubinsky WS, Brown RC (2010) TRPC-mediated actinmyosin contraction is critical for BBB disruption following hypoxic stress. Am J Physiol Cell Physiol 298: C1583-1593.
39. Henes J, Schmit MA, Morote-Garcia JC, Mirakaj V, Kohler D, Glover L, et al. (2009) Inflammation-associated repression of vasodilator-stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury. Faseb J 23: 4244-4255.
40. Austinat M, Braeuninger S, Pesquero JB, Brede M, Bader M, et al. (2009) Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema. Stroke 40: 285-293.
41. Raslan F, Schwarz T, Meuth SG, Austinat M, Bader M, et al. (2010) Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J Cereb Blood Flow Metab 30: 1477-1486.
42. Groeger M, Lebesgue D, Pruneau D, Relton J, Kim SW, et al. (2005) Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25: 978-989.
43. Dirnagl U (2006) Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab 26: 1465-1478.
44. Hauser W, Knobeloch KP, Eigentaler M, Gambaryan S, Krenn V, et al. (1999) Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc Natl Acad Sci USA 96: 8120-8125.
45. Clark WM, Lessov NS, Dixon MP, Eckenstein F (1997) Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res 19: 641-648.
46. Kleinschnitz C, Schwab N, Kraft P, Hagedorn I, Dreykluft A, et al. (2010) Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 115: 3835-3842.
47. Connolly Jr. ES, Winfree CJ, Stern DM, Solomon RA, Pinsky DJ (1996) Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. Neurosurgery 38: 523-532.
48. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, et al. (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17: 472-476.
49. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, et al. (1986) Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 176: 1304-1308.
50. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, et al. (2006) 1,026 Experimental treatments in acute stroke. Ann Neurol 59: 467-477.
51. Crossley NA, Sena E, Goehler J, Horn J, van der Worp B, et al. (2008) Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke 39: 929-934.
52. Van der Worp HB, de Haan P, Morrema E, Kalkman CJ (2005) Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia. J Neurol 252: 1108-1114.